Re: Breast cancer screening
It is now time to take heed to calls for there to be a controlled deimplementation of screening by mammography.    Mounting evidence about harms and overdiagnosis, together with an increasing and pressing need to use both our financial and health professional resources wisely, without wastage, indicate a strong imperative for those responsible to take action without any further prevarication. Citizens are not being served justly or well by profligate spending on interventions that are demonstrably damaging both citizens and the public purse. Harms to citizens, both accepters and decliners, and those treated and untreated, are numerous, and have been well-documented.
How much longer do we have to go on waiting for those responsible to acknowledge that breast screening by mammography as now offered is not fit for purpose, is wasting valuable resources and harming more citizens than it helps? It is time, as suggested , for them to acknowledge that “the logical consequence of recent evidence is to start a discussion about controlled deimplementation of invited screening with mammography.”
 Mette Kalager `Breast cancer screening` BMJ 2017;359:j5625 http://www.bmj.com/content/359/bmj.j5625
 Autier P, Boniol M, Koechlin A, Pizot C, Boniol M. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. BMJ 2017;359:j5224. http://www.bmj.com/content/359/bmj.j5224
 Doublvetsky J V, Robert V, Nicot P, Bour C. Collectif Cancer Rose. Rapid response to  above. http://www.bmj.com/content/359/bmj.j5224/rr-1
Competing interests: No competing interests